BMO Capital analyst Juan Sanabria raised the firm’s price target on Omega Healthcare to $45 from $44 and keeps a Market Perform rating on the shares as part of a broader research note on U.S. REITs. The firm is updating its model to reflect the recent interest rate changes, results, and/or discussions with company management, the analyst tells investors in a research note.